HealthDay News — For patients who have undergone percutaneous coronary intervention (PCI), routine follow-up coronary angiography (FUCAG) has no long-term clinical benefit, according to a study ...

Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...

WASHINGTON, A randomized evaluation of routine follow-up coronary angiography after percutaneous coronary intervention (PCI) found that there was no long-term clinical benefit compared to clinical ...

Adding intravascular imaging to coronary angiography may not only sharpen placement of coronary stents, as shown in many studies, it may also reduce in-hospital clinical risk and boost long-term ...

Please provide your email address to receive an email when new articles are posted on . Intravascular imaging-guided PCI demonstrated clinical benefit vs. angiography for left main CAD. Observed ...

One in 4 patients undergoing elective coronary angiography in the United States is asymptomatic, according to a study published online August 25, 2014, ahead of print in JAMA: Internal Medicine.

Please provide your email address to receive an email when new articles are posted on . IVUS-guided PCI reduced risk for target vessel failure for patients with ACS vs. angiography-guided PCI. Lower ...

MIAMI, FL — Use of coronary angiography and PCI after out-of-hospital cardiac arrest (OHCA) increased significantly over a 13-year period, according to new research [1]. However, "a significant ...

Three new studies show that too many patients with stable angina are still persuaded by cardiologists to undergo unnecessary elective angiography with subsequent percutaneous coronary intervention. It ...

Patients with CKD had twice the risk of target vessel failure after PCI compared with patients without CKD. The benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) extend ...

Results from Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast), a multi-center prospective, unblinded, randomized controlled trial were presented today as late-breaking clinical research ...